FDA's Pelvic Mesh Scrutiny May Have Limited Impact In MDL
By Sindhu Sundar ( January 6, 2016, 12:01 AM EST) -- The U.S. Food and Drug Administration's view that certain transvaginal meshes are now high-risk medical devices that must meet strict safety assessments appears to support mesh implant patients in federal multidistrict litigation, but experts say defendants can still blunt its impact in the courtroom by trying to block juries from hearing about the development....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.